Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Immunic, Inc. (IMUX)

Atara Biotherapeutics, Inc. and Immunic, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Immunic, Inc. are of similar size ($96.9M and $96.9M). Immunic, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Atara Biotherapeutics, Inc. leads on 7 and Immunic, Inc. on 4.

Valuation

Metric ATRA IMUX Biotechnology median
P/E n/m n/m 8.50
P/S 22.28 n/m 9.71
P/B n/m 2.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 20.69 n/m 9.21
Earnings yield (12.85%) (62.84%) (33.15%)
Free cash flow yield (15.24%) (29.71%) (25.50%)

Profitability

Metric ATRA IMUX Biotechnology median
Gross margin 91.38% 0.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (138.17%) (56.36%)
Return on assets (57.62%) (101.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA IMUX Biotechnology median
Revenue growth (TTM) (96.72%) — 6.02%
EPS growth (last fiscal year) 122.52% 38.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 5.05 4.72
Net debt to EBITDA (0.22) 0.15 0.96

Dividend

Metric ATRA IMUX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATRA IMUX Biotechnology median
Market cap 96.86m 96.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack